Innovative Trials celebrates initiative success with industry peers at 2024 PMEA Awards
Innovative Trials, a global clinical trial patient recruitment and retention company, has been recognized for its commitment to excellence and best practice at the 2024 PMEA industry awards last night (Thursday 21 November). The company was a finalist in the Excellence in Collaboration and Partnerships category for its Retention Patch Program initiative. Created in partnership with US non-profit Oliver Patch Project and launched in February 2024, it creates an engaging and supportive experience for children and teenagers participating in pediatric clinical trials, boosting retention rates.
Kate Shaw, CEO of Innovative Trials, said: “Having only launched the Retention Patch Program a matter of months ago, I’m incredibly proud of the difference it is already making to our clients. To have this recognized by our peers is a real achievement for the whole team. While we are naturally saddened that we didn’t win our category, I want to congratulate Roche who did, as well as all the other exceptional winners on the night.”
Judges commented on Innovative Trials’ finalist entry in the Excellence in Collaboration and Partnerships category with the following: “Innovative Trials outlined a clear rationale for change. They clearly defined the current problem/situation and showed a clear understanding of the patient experience, drawing on experience in clinical trial recruitment. The plan was clearly set out to address the situation, using patches to drive retention, in partnership with OPP [Oliver Patch Project]. It had strong goals.”
The Retention Patch Program enables pediatric clinical trial participants to collect a series of colorful and unique patches that can be ironed onto garments and worn like badges of honor. These patches are given out at set milestones during the study and only those who remain in the trial until the very end will collect them all. The initiative has already attracted significant interest from several pharmaceutical companies and research organizations, and is currently supporting 260 children and young people under the age of 18.
Earlier this year, Innovative Trials’ CEO, Kate Shaw, won the Woman in Pharma award at the Pharma Industry Awards UK. The company has also previously been named Best Global Patient Recruitment Company by the Healthcare & Pharmaceutical Awards and was awarded the Queen’s Award for Enterprise in 2020 for international excellence.
-Ends-
For more information, or to request an interview with Kate Shaw, please contact Laura Gibson at Presence Media via +44 7771 933609 or [email protected]
Notes to editors
About Innovative Trials
Innovative Trials is a prominent international company specializing in patient recruitment and retention for clinical trials. Boasting 14 years of experience, Innovative Trials provides three fundamental services in this domain:
- 1:1 In-country Recruitment Coaching & Site Support, facilitated by in-country patient recruitment experts operating in more than 70 countries,
- Site & Patients Educational Materials,
- Navigator, a patient support center for referral pre-screening and retention.
With expertise in over 400 trials, 25 therapeutic areas, and over 90 conditions, Innovative Trials has established itself as a trusted and seasoned partner for pharmaceutical companies, contract research organizations (CROs) and biotechnology companies. For more information, visit www.innovativetrials.com
About Oliver Patch Project
The Oliver Patch Project (OPP) is a 501(c)(3) nonprofit corporation that empowers children and teens to find their inner warriors, as they endure life-changing milestone events, by providing a bit of sunshine throughout their cancer journey.
OPP’s mission is to create a free, fun, engaging platform where children, teens and their families can connect through a series of unique patches created by artists and designers just for them.
We believe in the power of positivity to promote healing and are serving families in all 50 states!